The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21

Central cartilage tumour Femur Solitary

Journal

Journal of clinical orthopaedics and trauma
ISSN: 0976-5662
Titre abrégé: J Clin Orthop Trauma
Pays: India
ID NLM: 101559469

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 30 03 2022
revised: 07 07 2022
accepted: 19 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

To determine the incidence of central cartilage tumours (CCTs) in the femur and the impact of site (proximal, mid and distal thirds) on tumour grade. To compare study results with historically published data. Retrospective review of solitary CCTs arising in the femur over the past 13 years. Data collected included location (proximal, mid and distal thirds) and final diagnosis in terms of tumour grade based on imaging features ± histology. Case material collected from three bone tumour textbooks provided historical data. 430 solitary CCTs were included in the femur. 73% cases arose in the distal, 3.7% in the mid and 23% in the proximal femur. The ratio of "benign" (combining enchondroma and atypical cartilaginous tumour (ACT)) to higher grade chondrosarcoma (CS) was 11:1 in the distal, 1:1 in the mid and 1:1.5 in the proximal femur, the distribution of benign to malignant tumours being significantly different between the regions (F test, p < 0.05). Comparison with historical data showed a reversal of the benign (enchondroma) to malignant (ACT and higher grade CS) of 30%:70%-84%:16% in the current series. The site of origin of a CCT in the femur has an impact on final diagnosis with CS uncommon in the distal as compared with the mid and proximal femur. This is in contradistinction to historical data where the incidence of CS exceeded that of enchondroma at all sites.

Identifiants

pubmed: 35959501
doi: 10.1016/j.jcot.2022.101953
pii: S0976-5662(22)00189-8
pmc: PMC9358228
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101953

Informations de copyright

© 2022 Delhi Orthopedic Association. All rights reserved.

Déclaration de conflit d'intérêts

No conflicts of interest.

Références

Skeletal Radiol. 2021 Jun;50(6):1189-1196
pubmed: 33169221
Int J Surg Oncol. 2010;2010:270195
pubmed: 22312488
Radiographics. 1998 Sep-Oct;18(5):1213-37; quiz 1244-5
pubmed: 9747616
Ann Emerg Med. 1999 Jan;33(1):85-91
pubmed: 9867892
J Clin Orthop Trauma. 2021 Feb 27;17:106-111
pubmed: 33747783
J Surg Oncol. 2008 Nov 1;98(6):421-6
pubmed: 18668642
J Bone Joint Surg Am. 2018 Feb 21;100(4):316-325
pubmed: 29462035
AJR Am J Roentgenol. 1997 Oct;169(4):1097-104
pubmed: 9308471
Acta Orthop. 2020 Aug;91(4):471-478
pubmed: 32429792
Bone Joint J. 2021 May;103-B(5):984-990
pubmed: 33934657
Eur J Surg Oncol. 2018 Sep;44(9):1412-1418
pubmed: 29929901
Clin Radiol. 2020 Jul;75(7):533-537
pubmed: 32183998
Bone Joint J. 2019 Mar;101-B(3):266-271
pubmed: 30813783
J Surg Oncol. 2016 Dec;114(8):987-991
pubmed: 27696436
Clin Radiol. 2004 Mar;59(3):268-72
pubmed: 15037140
Clin Imaging. 2011 Sep-Oct;35(5):378-84
pubmed: 21872128
Skeletal Radiol. 2021 Jun;50(6):1131-1140
pubmed: 33123743
Skeletal Radiol. 2021 Feb;50(2):407-415
pubmed: 32794057
Eur Radiol. 2013 Nov;23(11):3140-52
pubmed: 23771600
Skeletal Radiol. 2020 Jul;49(7):1115-1125
pubmed: 32147756
Cancers (Basel). 2021 Aug 13;13(16):
pubmed: 34439246
Cancer. 2019 Oct 1;125(19):3288-3291
pubmed: 31381137
Am J Surg Pathol. 2009 Jan;33(1):50-7
pubmed: 18852676
Acta Oncol. 2019 Mar;58(3):273-282
pubmed: 30632866
AJR Am J Roentgenol. 2008 Jun;190(6):1611-5
pubmed: 18492914
Eur J Orthop Surg Traumatol. 2017 Aug;27(6):805-811
pubmed: 28501961
Skeletal Radiol. 1997 Jun;26(6):325-53
pubmed: 9229417
Arch Pathol Lab Med. 2020 Jan;144(1):71-82
pubmed: 31877083
Int J Surg Pathol. 2008 Jan;16(1):31-7
pubmed: 18203781
Surg Oncol. 2018 Sep;27(3):402-408
pubmed: 30217294
Clin Orthop Relat Res. 2010 Oct;468(10):2765-73
pubmed: 20574801
Clin Radiol. 2019 Dec;74(12):962-971
pubmed: 31587800
Semin Musculoskelet Radiol. 2019 Feb;23(1):3-18
pubmed: 30699449
Clin Orthop Relat Res. 2017 Mar;475(3):808-814
pubmed: 26883651
Eur J Radiol. 2015 Nov;84(11):2222-30
pubmed: 26220916
J Oncol. 2012;2012:437958
pubmed: 22593766
Acta Oncol. 2020 Feb;59(2):242-246
pubmed: 31769322
Cureus. 2020 Oct 29;12(10):e11237
pubmed: 33269165
Musculoskelet Surg. 2018 Aug;102(2):95-109
pubmed: 28986742
Br J Radiol. 2021 Oct 1;94(1126):20201404
pubmed: 34111983
Int Orthop. 2006 Dec;30(6):437-44
pubmed: 16944143
J Urol. 2014 Sep;192(3):891-8
pubmed: 24631109
Eur Radiol. 2018 Jan;28(1):398-409
pubmed: 28695356
Clin Radiol. 2019 Jul;74(7):517-526
pubmed: 30827492
J Bone Joint Surg Am. 2007 Oct;89(10):2113-23
pubmed: 17908885
Indian J Radiol Imaging. 2021 Oct 06;31(3):582-585
pubmed: 34790301
Eur Radiol. 2015 Dec;25(12):3480-7
pubmed: 25994192
Cancer. 1998 Nov 15;83(10):2105-19
pubmed: 9827715
Eur J Radiol. 2021 Apr;137:109579
pubmed: 33578088
Eur Radiol. 2014 Jan;24(1):232-40
pubmed: 24337911

Auteurs

A M Davies (AM)

Department of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.

A Patel (A)

Department of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.

C Azzopardi (C)

Department of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.

S L James (SL)

Department of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.

R Botchu (R)

Department of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.

L Jeys (L)

Departments of Orthopaedic Oncology, Royal Orthopaedic Hospital, Birmingham, UK.

Classifications MeSH